The kinetics of oxidation of isoniazid in acidic medium was studied spectrophotometrically. The reaction between QDC and isoniazid in acid medium exhibits (4:1) stoichiometry (QDC:isoniazid). The reaction showed first order kinetics in quinolinium dichromate (QDC) concentration and an order of less than unity in isoniazid (INH) and acid concentrations. The oxidation reaction proceeds via a protonated QDC species, which forms a complex with isoniazid. The latter decomposes in a slow step to give a free radical derived from isoniazid and an intermediate chromium(V), which is followed, by subsequent fast steps to give the products. The reaction constants involved in the mechanism are evaluated. Isoniazid was analyzed by kinetic methods in pure and pharmaceutical formulations.
The kinetics and mechanism of oxidation by chromium(VI) has been well studied, and chromic acid as one of the most versatile of the available oxidizing agents reacting with diverse kinds of substrates.
Nowadays, the development of newer chromium(VI) reagents [1] [2] [3] [4] [5] [6] [7] for the oxidation of organic substrates continues to be a subject of interest. The reagent employed in this investigation, quinoliniumdichromate (QDC), (C9H7NH + )2Cr2O7 2- , has been found to be a useful and versatile oxidant 6 that deserves further evaluation. We are particularly interested to see the mechanism involved in the oxidation of drug molecules by this new oxidant QDC. Since the chromium exhibits different oxidation states during oxidation, such as chromium(V), chromium(IV) and chromium(III), the reaction might involve several complexities.
Pyridine-4-carboxylic acid hydrazide, commercially known as isoniazid (INH) , is an antitubercular drug, and is now widely used together with rifampicin and streptomycin for the chemotherapy of tuberculosis. The drug has been reported to affect virtually every aspect of mycobacterial metabolism. Many components of mycobacterium tuberculosis have been proposed as possible targets of isoniazid. It inhibits the synthesis of mycolic acids (long-chain α-branched β-hydroxylated fatty acids) in mycobacterium tuberculosis by affecting an enzyme mycolase synthase, which is unique for mycobacteria. 8 This has prompted many researchers to develop accurate and rapid methods for the determination of isoniazid. Of the various techniques used for the determination of isoiazid, FIA-spectroflurometry, 9 polarography, 10 adsorptive stripping voltammetry, 11 selective adsorption 11 are of high cost. Other methods include high-performance liquid chromatography 12 and direct potentiometric titration. 13 Many spectrophotometric methods have been described for the determination of isoniazid; some of these are time bound, 14 involve tedious extraction, 15 require heating, 16 need cooling to lower the temperature for a long time 17 or are less sensitive. 18 The United States Pharmacopoeia (USP) method 19 involves a titration procedure, which is both laborious and time consuming. Hence, it was planned to develop a sensitive and economically viable technique, like a kinetic procedure. The proposed method enables isoniazid analysis in the range of 1.0 × 10 -4 -5.0 × 10 -3 mol dm -3 . The present study deals with the title reaction to investigate the redox chemistry of QDC in such media, to arrive at a plausible mechanism and also the analysis of isoniazid.
Experimental

Apparatus
A Peltier Accessory (Temperature control) attached Varian CARY 50 Bio UV-vis Spectrophotometer with matched 1 cm quartz cells was used for all absorbance measurements.
Reagents and samples
Reagent-grade chemicals and doubly distilled water were used throughout. Quinolinium dichromate was prepared by the reported method. 6 The purity was checked with I.R. and NMR spectra. The QDC solution was prepared by dissolving QDC in water and its concentration was determined iodometrically. 6 A solution of isoniazid (Sisco Chem.) was prepared by dissolving an appropriate amount of sample in distilled water. The chromium(III) solution was prepared by dissolving chromium potassium sulfate (Cr2(SO4)3·K2SO4·24H2O) (BDH) in water. Perchloric acid (Merck) and sodium perchlorate (BDH) were used to keep the required acidity and to maintain the ionic strength, respectively.
Kinetic procedure
All kinetic measurements were performed under pseudo-first order conditions where isoniazid used was at least 10 fold excess over [QDC] at a constant ionic strength of 1 × 10 -2 mol dm -3 . The reaction was initiated by mixing previously thermostatted solutions of QDC and isoniazid, which also contained the required quantities of HClO4 and NaClO4 to maintain the required acidity and ionic strength, respectively. The temperature was maintained at 25 ± 0.1˚C. The course of the reaction was followed by monitoring the decrease in the absorbance of QDC. The first-order rate constants (kobs) were evaluated by plots of log(At -A∞) versus time by fitting the data to the expression At = A∞ + (A0 -A∞)·exp(-kobst), where At, A0 and A∞ are the absorbances of QDC at time t, 0 and ∞, respectively. The plots in almost all cases were linear up to 85% of the reaction, and kobs were reproducible within ± 5%.
Determination of pure drug
The above kinetic procedure was applied for a series of standard solutions of isoniazid and the absorbance for 120 s was measured directly at 380 nm. The isoniazid concentration was then calculated from the corresponding equation for the calibration graph for a fixed-time method.
Analysis of pharmaceutical formulations
Twenty tablets of isoniazid were finely powdered. An amount equivalent to 25 mg of the drug was weighed accurately and transferred into a 100 ml beaker. Using a magnetic stirrer, the powder was completely disintegrated in water. The solution was filtered and the filtrate was made up to 100 ml with water. An aliquot of the drug solution was analyzed as described earlier.
For the syrup, an appropriate volume of the sample was analyzed for isoniazid using the procedure described for a pure sample.
Results and Discussion
Stoichiometry
The results indicated that four moles of QDC were consumed by three moles of isoniazid, as follows:
The main reaction products were identified as isonicotinic acid by its I.R. spectrum, which showed a band at (ν) 1690 cm -1 due to >C=O stretching of acid and a broad band at 2840 cm -1 due to O-H stretching and Cr(III) by its visible spectrum showing absorbance maxima at 580 nm. Isonicotinic acid, which was further characterised by the 1 HNMR spectrum (DMSO), showed chemical shifts (δ) at 8.7 ppm (s, due to aromatic 2H(a)), 7.52 ppm (s, at due to aromatic 1H(b)) and 10.6 (s, 1H, carboxylic OH), respectively. It was observed that the acid did not undergo further oxidation under the present kinetic conditions.
Reaction order
The reaction orders were determined from the slopes of log(kobs) versus log(concentration) plots by varying the concentration of the reductant and acid in turn while keeping others constant.
The linearity of a plot of log(At -A∞) versus time indicates the order in [QDC] to be unity. This was also confirmed by varying [QDC], which did not show any change in the pseudo-first order rate constants (kobs) ( Table 1 ). The apparent order in [INH] was found to be less than unity ( Table 1 ). The rate constants increased with an increase of the acid concentration (Table 1) It was found that change in the ionic strength and the dielectric constant had negligible effect on the rate of the reaction. A test of free radicals was found to be positive.
Effect of temperature
The rate constants (k) of the slow step of the mechanism were obtained from the intercepts of the plots of 1/kobs versus 1/[INH] at four different temperatures. The energy of activation corresponding to these constants was evaluated from the plot log k versus 1/T (r > 0.9935, S < 0.0213) and the activation parameters were obtained as Ea, ∆H # , ∆S # and ∆G # , 46 ± 3 kJ mol -1 , 50 ± 3 kJ mol -1 , -30 ± 2 J K -1 mol -1 and 53 ± 7 kJ mol -1 , respectively.
The increase in the oxidation rate with acidity suggested the involvement of a protonated chromium(VI) species in the prior equilibrium step. There have been earlier reports of the involvement of such species in chromic acid oxidation. 20 Here, QDC in the presence of acid forms a protonated species. The protonated species of QDC reacts with isoniazid to form a complex, which then decomposes in a rate-determining step to give the free-radical, derived from isoniazid and the intermediate chromium(V) being generated. The free-radical intermediate further reacts with one more molecule of QDC in a fast step to give the final product, iso-nicotinic acid (pyridine 4-carboxylic acid) and intermediate chromium(V). This step is further followed by subsequent fast steps to give the products in order to satisfy the stoichiometry.
The initiation of polymerization of acrylonitrile indicated the possibility of a free-radical intervention. The results can be accommodated by Scheme 1. They can also be followed by other fast steps to give the products.
Spectroscopic evidence was obtained for complex formation between the oxidant and substrate, obtained from UV-vis spectra of the isoniazid, QDC and mixture of both. A bathochromic shift of about 5 nm from 390 to 395 nm in the spectra of QDC was observed, and hyperchromicity was observed at 395 nm.
This was also evident from Michaelis-Menten plot, 1/kobs versus 1/[INH] plot (Fig. 1) complex formation between the substrate and oxidant has also been observed in other studies. 21 The observed modest enthalpy of activation and a relatively low value of the entropy of activation, as well as a higher rate constant for the slow step, indicates that the oxidation presumably occurs via an innersphere mechanism. This conclusion is supported by earlier observations. 22 Since the oxidation of isoniazid by QDC is a noncomplementary reaction, it may occur by the intervention of reactive chromium(IV) and chromium(V) species.
The intervention of chromium(IV) is evident from the progressive rate decrease in the presence of increasing amounts of added manganese(II). Such results have also been obtained for the chromium(VI) oxidation of 2-propanol in aqueous acetic acid. 23 The intervention of chromium(V) is evident from an induction experiment with iodide. The induced oxidation of iodide yields two equivalents of iodine for each equivalent of the inductor oxidized. The induction factor for iodide oxidation is nearly two, which indicates that the active oxidizing agent is pentavalent chromium.
Scheme 1 leads to the rate law (2):
The
terms (1 + K1K2[QDC][H + ]) and (1 + K1[QDC] + K1K2[INH][QDC])
in the denominator approximate to unity in view of the low concentration of quinolinium dichromate used. Hence (omitting the subscripts T and f ),
The rate law (3) may be rearranged as follows, which is suitable for verification: 
kK1K2[INH]T[QDC]T[H + ]T -------------------------(1 + K1K2[QDC][H + ])(1 + K1[H + ] + K1K2[INH][H + ]) × (1 + K1[QDC]+ K1K2[INH][QDC])
conditions were calculated according to Eq. (3) and compared with the experimental data ( Table 1 ). The experimental rate constants are in good agreement with the calculated values. The negative value of the entropy of activation indicated that the complex is more ordered than the reactants. The observed modest activation energy and sizeable entropy of activation support a complex transition state in the reaction. The negligible effect of the ionic strength on the rate of reaction is in the right direction, since an ion and a neutral molecule are involved 24 in Scheme 1.
Kinetic determination of isoniazid in pharmaceutical formulations
The initial-rate, rate constant, constant concentration and constant time methods 25 were used for determining isoniazid, and the best method was chosen based on applicability, the slope of the calibration graph, the intercept and the correlation coefficient (r). Initial-rate method. In this method, graphs of the rate (at the beginning of the reaction) versus the isoniazid concentration were not easy to obtain because the reaction was fast. Thus, the tangents to the curves at zero time were not easy to draw. This method was therefore abandoned. Rate-constant method. Pseudo-first order rate constants were calculated for isoniazid concentrations in the range from 1 × 10 -4 to 2 × 10 -2 mol dm -3 and are presented in Table 2 The range of isoniazid concentrations giving the most acceptable calibration graph with the above equation was 1 × 10 -4 to 5 × 10 -3 mol dm -3 (i.e., 13.7 -685.7 µg cm -3 ). Fixed-concentration method. A pre-selected value of the absorbance was fixed and the time was measured for different isoniazid concentrations ( Table 2 ). The reciprocal of time (1/t) versus the initial concentration of isoniazid was plotted, which could be used as a calibration graph. The following equation Fig. 1 Verification of the rate law (3) in the form of (4) on the QDC oxidation of an isoniazid in an aqueous acid medium. Conditions as in Table 1 .
Scheme 1 acceptable calibration graph with the above was very limited, 1 × 10 -4 -5 × 10 -4 mol dm -3 (i.e., 13.7 -68.6 µg cm -3 ), which could be a disadvantage. Fixed-time method. A pre-selected time was fixed and the absorbance was measured for different concentrations of isoniazid (Table 2) . A plot of the absorbance versus the initial concentration of isoniazid was drawn, which was linear and could be used as a calibration graph (Fig. 2) . This led to the following equation:
The range of the isoniazid concentrations giving the most acceptable calibration graph with above was 1 × 10 -4 -3 × 10 -3 mol dm -3 (i.e., 13.7 -411.4 µg cm -3 ). The best correlation coefficient was obtained for the fixedtime method, and the value of the slope was also high. Even though the range was limited compared to the rate-constant method, the fixed-time method was found to be more applicable. Application of the method. The applicability of the fixed-time method was examined as an assay of pharmaceutical preparations. The results of the assay of isoniazid tablets and syrups are tabulated in Table 3 (a) and are compared with the official 19 method. The results of urine and blood samples are given in Table 3(b) . Assay procedure for drug in urine. A known amount of INH was added to 5 ml of urine sample. To this was added 0.5 g of lead nitrate to precipitate out the present chlorides. The solution was filtered and excess lead present in the filtrate was removed by adding 8 M sulfuric acid. The solution was again filtered. The pH of the filtrate was adjusted to 3.6. A suitable amount of an aliquot was analyzed for the quantification of INH, as described for the pure drug. Assay procedure for drug in blood. One milliliter of blood was spiked with a known amount of INH before the addition of sodium citrate. The citrated blood was deprotonated with trichloroacetic acid and filtered. The filtrate was diluted with distilled water to 100 ml in a calibrated flask. An appropriate amount of an aliquot was taken, neutralized with a dilute sodium hydroxide solution and analyzed as described for the pure drug. Interference studies. In order to assess the possible analytical applications of the proposed method, the effects of some substances that often accompany isoniazid in various pharmaceutical products were studied by adding different amounts of substances to 20 µg cm -3 of isoniazid. An attractive feature of the method is its relative freedom from interference by the usual tablet diluents and excipients in amounts far in excess of their normal occurrence in pharmaceutical preparations. The results are given in Table 4 . Statistical analysis of the results in comparison with the official method. The performance of the proposed method was judged by calculating the Student t-test and variance ratio F-test. At the 95% confidence level, the calculated t-and F-values do not exceed the theoretical values ( Table 3 ), indicating that there is no significant difference between the proposed method and the official method. 19 From an analytical point of view, it is concluded that the described procedure allows for the determination of isoniazid in pure and pharmaceutical dosage forms.
Unlike the spectrofluorometer, as well as gas chromatographic and HPLC procedures, the instrument is simple and inexpensive. Its importance lies in the chemical reaction upon which the procedure is based, rather than sophistication of the instrument. This aspect of the kinetic method of determination is of major interest in analytical pharmacy, since it offers a distinct possibility for the assay of a particular component in complex dosage formulations. 
